Gyre Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Gyre Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14188% to $113,450,000. Profit margin reached -82%. Total operating expenses were $176,044,000.
Profit Margin
| 2014 | 275K | -32.62M | -11862.91% |
|---|---|---|---|
| 2015 | 1.75M | -14.76M | -843.54% |
| 2016 | 399K | -16.94M | -4246.87% |
| 2017 | 1.01M | -21.56M | -2117.98% |
| 2018 | 6K | -30.05M | -500916.67% |
| 2019 | 0 | -52.88M | |
| 2020 | 20.94M | -55.54M | -265.14% |
| 2021 | 7.33M | -87.93M | -1198.32% |
| 2022 | 794K | 2.30M | 289.92% |
| 2023 | 113.45M | -92.93M | -81.92% |
GYRE Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 113.45M | 794K | 7.33M | 20.94M | 0 | 6K | 1.01M | 399K | 1.75M | 275K |
Cost of revenue | 4.63M | 798K | 7.38M | 9.16M | 43.85M | 21.47M | 12.84M | 10.55M | 5.95M | 5.26M |
Gross profit | 108.81M | -4K | -42K | 11.78M | -43.85M | -21.46M | -11.82M | -10.15M | -4.20M | -4.99M |
Operating exp. | ||||||||||
Research and development | 13.78M | 13.03M | 68.88M | 52.97M | 43.85M | 21.47M | 12.84M | 11.55M | 5.95M | 19.49M |
Selling and marketing | 61.15M | 54.23M | 44.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 176.04M | 30.40M | 87.85M | 69.15M | 57.27M | 33.82M | 22.84M | 20.81M | 15.55M | 29.67M |
Operating income | -67.23M | -8.61M | -87.89M | -57.37M | -57.27M | -33.82M | -21.82M | -20.41M | -13.80M | -29.71M |
Other income (expenses), net | -9.73M | 717K | -39K | 1.12M | 2.09M | 1.53M | 261K | 3.47M | -960K | 575K |
Income before tax | -76.96M | -7.89M | -87.93M | -56.24M | -55.17M | -30.05M | -21.56M | -16.94M | -14.76M | -29.13M |
Income tax expense | 8.51M | 348K | -39K | -699K | -2.29M | 3.76M | -173K | 3.08M | 518K | 3.48M |
Net income | -92.93M | 2.30M | -87.93M | -55.54M | -52.88M | -30.05M | -21.56M | -16.94M | -14.76M | -32.62M |
Earnings per share | ||||||||||
Basic EPS | -1.41 | 0.03 | -2.87 | -2.9 | -4.41 | -2.68 | -6.3 | -21.76 | -49.99 | -101.4 |
Diluted EPS | -1.41 | 0.03 | -2.87 | -2.9 | -4.41 | -2.68 | -6.3 | -21.76 | -49.99 | -101.4 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |